Strs Ohio Sells 141,300 Shares of Sabra Healthcare REIT, Inc. $SBRA

Strs Ohio cut its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 16.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 729,700 shares of the real estate investment trust’s stock after selling 141,300 shares during the quarter. Strs Ohio’s holdings in Sabra Healthcare REIT were worth $14,032,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of SBRA. Principal Financial Group Inc. lifted its stake in Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares in the last quarter. Bank of Montreal Can increased its position in shares of Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after acquiring an additional 211,686 shares in the last quarter. Legal & General Group Plc increased its position in shares of Sabra Healthcare REIT by 16.5% during the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after acquiring an additional 201,667 shares in the last quarter. UBS Group AG raised its holdings in shares of Sabra Healthcare REIT by 143.1% during the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock worth $27,657,000 after acquiring an additional 859,584 shares during the period. Finally, Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT by 3.2% during the fourth quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock worth $45,133,000 after acquiring an additional 73,281 shares during the period. 99.40% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SBRA. Truist Financial upped their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. UBS Group set a $19.00 price target on Sabra Healthcare REIT in a report on Thursday, June 18th. Citigroup downgraded Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $24.00 to $19.00 in a report on Monday, June 22nd. Finally, Scotiabank dropped their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Four research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $21.30.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $20.16 on Friday. The company has a market cap of $5.08 billion, a P/E ratio of 32.00, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $21.28. The company has a fifty day simple moving average of $19.71 and a 200 day simple moving average of $19.67. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the firm posted $0.37 EPS. The company’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.